Jiangsu Kanion Pharmaceutical Co Ltd Asset Resilience Ratio
Jiangsu Kanion Pharmaceutical Co Ltd asset resilience ratio. Jiangsu Kanion Pharmaceutical Co Ltd (600557) has an Asset Resilience Ratio of 0.29% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Jiangsu Kanion Pharmaceutical Co Ltd (600557) defensive interval to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Jiangsu Kanion Pharmaceutical Co Ltd (2011–2024)
Asset resilience ratio of Jiangsu Kanion Pharmaceutical Co Ltd from 2011 to 2024. This chart shows how Jiangsu Kanion Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. Read 600557 liabilities breakdown for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Jiangsu Kanion Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see 600557 asset base.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥20.00 Million | 0.29% |
| Total Liquid Assets | CN¥20.00 Million | 0.29% |
Asset Resilience Insights
- Limited Liquidity: Jiangsu Kanion Pharmaceutical Co Ltd maintains only 0.29% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Jiangsu Kanion Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio
Compare Jiangsu Kanion Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Takeda Pharmaceutical Company Limited
F:TKDA |
Drug Manufacturers - Specialty & Generic | 0.69% |
|
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK |
Drug Manufacturers - Specialty & Generic | 4.94% |
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2 |
Drug Manufacturers - Specialty & Generic | 0.20% |
|
Ajanta Pharma Limited
NSE:AJANTPHARM |
Drug Manufacturers - Specialty & Generic | 14.99% |
|
Changchun High & New Technology Industries Group Inc
SHE:000661 |
Drug Manufacturers - Specialty & Generic | 5.50% |
|
Jiangsu Nhwa Pharmaceutical Co Ltd
SHE:002262 |
Drug Manufacturers - Specialty & Generic | 26.45% |
|
Porton Fine Chemicals Ltd
SHE:300363 |
Drug Manufacturers - Specialty & Generic | 6.85% |
|
Jubilant Pharmova Limited
NSE:JUBLPHARMA |
Drug Manufacturers - Specialty & Generic | 1.26% |
Jiangsu Kanion Pharmaceutical Co Ltd Asset Resilience Ratio by Year (2011–2024)
Jiangsu Kanion Pharmaceutical Co Ltd asset resilience ratio by year from 2011 to 2024. The table below shows the annual Asset Resilience Ratio data for Jiangsu Kanion Pharmaceutical Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 0.58% | CN¥40.00 Million ≈ $5.85 Million |
CN¥6.91 Billion ≈ $1.01 Billion |
-5.88pp |
| 2023-12-31 | 6.46% | CN¥460.00 Million ≈ $67.31 Million |
CN¥7.12 Billion ≈ $1.04 Billion |
+3.96pp |
| 2022-12-31 | 2.50% | CN¥170.00 Million ≈ $24.88 Million |
CN¥6.80 Billion ≈ $994.44 Million |
-0.42pp |
| 2021-12-31 | 2.92% | CN¥176.00 Million ≈ $25.75 Million |
CN¥6.02 Billion ≈ $880.63 Million |
+2.85pp |
| 2020-12-31 | 0.07% | CN¥4.50 Million ≈ $658.49K |
CN¥6.12 Billion ≈ $895.33 Million |
+0.06pp |
| 2019-12-31 | 0.01% | CN¥800.00K ≈ $117.07K |
CN¥6.11 Billion ≈ $894.21 Million |
+0.00pp |
| 2018-12-31 | 0.01% | CN¥614.58K ≈ $89.93K |
CN¥5.60 Billion ≈ $819.89 Million |
-0.21pp |
| 2015-12-31 | 0.22% | CN¥9.30 Million ≈ $1.36 Million |
CN¥4.30 Billion ≈ $629.88 Million |
+0.18pp |
| 2011-12-31 | 0.04% | CN¥1.00 Million ≈ $146.33K |
CN¥2.58 Billion ≈ $377.74 Million |
-- |
About Jiangsu Kanion Pharmaceutical Co Ltd
Jiangsu Kanion Pharmaceutical Co.,Ltd. researches and develops, produces, and sells Chinese medicines. It also offers medicines in the fields of anti-infections, orthopedics, gynecology, cardio and cerebrovascular, tonic-class, and others. In addition, the company provides herb extracts and formula granules, as well as OEM/ODM services. Jiangsu Kanion Pharmaceutical Co.,Ltd. was founded in 1975 a… Read more